BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2008
View Archived Issues
Further data on pregabalin efficacy in generalized anxiety disorder reported
Read More
Adenosine A3 receptor expression correlated with responses to CF-101 in RA patients
Read More
QUATRx reports results from two phase I clinical studies of sobetirome
Read More
Novel compounds for cancer treatment disclosed in recent patent literature
Read More
Genetic variation in drug transporter ABCB1 is linked to antidepressant efficacy
Read More
Sinclair's new herpes simplex treatment registered in the E.U.
Read More
Viventia Biotech to consider strategic alternatives
Read More
Transtec provides a safe alternative in opioid treatment
Read More
Recent Novartis patents describe novel agents for asthma therapy
Read More
M's Science initiates European phase II stroke recovery study
Read More
Novel treatment options for septic shock imparted in recent Abbott and Takeda patents
Read More
FDA accepts BLA filing for Dysport in cervical dystonia
Read More
AMAG provides additional information on clinical development program for ferumoxytol
Read More
CYT-387 shows encouraging ex vivo results in patients with myeloproliferative disorders
Read More
Oncolytics meets criteria to proceed to full enrollment in phase II clinical trial of Reolysin
Read More
Millennium and Harvard Medical School sign agreement for protein homeostasis research
Read More
Abbott is to invest up to USD 40 million in Ibis Biosciences
Read More
Kiadis reports successful completion of phase II clinical trial of Rhitol for GvHD
Read More
FDA grants priority review for Schering-Plough's Peg-IFN for stage III melanoma
Read More
Preclinical antitumor profile of proteasome inhibitor CEP-18770 reported
Read More
AVEO initiates phase Ib clinical trial of AV-951 in metastatic renal cell carcinoma
Read More
Pfizer obtains Japanese approval for Revatio in pulmonary hypertension
Read More
TargeGen commences clinical trial of TG-101348 in myeloproliferative disease
Read More
MediciNova's MN-166 reduces persistent black hole formation in MS
Read More
Studies show safety and efficacy of elvucitabine in HIV
Read More